Step Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$136M Buy
705,000
+10,000
+1% +$1.08M 53.92% 1
2026
Q2
$48.7M Buy
695,000
+50,000
+8% +$2.59M 10.51% 3
2026
Q1
$32.8M Hold
645,000
– – 13.15% 3
2025
Q4
$19M Buy
+645,000
New +$17.5M 8.71% 5

Other funds holding MRNA

Step Capital Management's MRNA Position: Q3 2026 in Review

Step Capital Management increased its Moderna (MRNA) stake by 1.4% in Q3 2026, buying an estimated $1.08M and bringing the position to 705,000 shares worth $136M. The position accounts for 53.92% of the portfolio, ranked #1.

Step Capital Management first reported a position in MRNA in Q4 2025 and has held it in 4 quarters since. 1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Step Capital Management held 705,000 shares of Moderna worth $136M as of Q3 2026.
  • Step Capital Management bought 10,000 Moderna shares in Q3 2026, an estimated $1.08M.
  • Moderna made up 53.92% of Step Capital Management's portfolio in Q3 2026, its #1 holding.
  • Step Capital Management first reported a position in Moderna in Q4 2025 and has held it in 4 quarters since.
  • 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Step Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.